Solid Tumor, Adult Trials in France, 2026
Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.
About this register
This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,714 studies in total at the last sync on 11 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.
This page shows the 12 of those studies listing the condition Solid Tumor, Adult.
How many Solid Tumor, Adult trials are recruiting in France?
9 of the 12 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.
Summary by phase
| Phase | Studies | Recruiting | Share |
|---|---|---|---|
| Phase 1/2 | 5 | 4 | 41.7% |
| Phase 1 | 4 | 3 | 33.3% |
| Not applicable | 2 | 2 | 16.7% |
| Phase 2 | 1 | 0 | 8.3% |
Most active sponsors
| Lead sponsor | Studies | Recruiting |
|---|---|---|
| Gustave Roussy, Cancer Campus, Grand Paris | 2 | 2 |
| Centre Oscar Lambret | 1 | 1 |
| Corbus Pharmaceuticals Inc. | 1 | 1 |
| Egle Therapeutics | 1 | 1 |
| ImCheck Therapeutics, an Ipsen company | 1 | 0 |
| Institut Bergonié | 1 | 0 |
| Kumquat Biosciences Inc. | 1 | 0 |
| Pierre Fabre Medicament | 1 | 1 |
| Relay Therapeutics, Inc. | 1 | 1 |
| TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 1 | 1 |